DCF — RIVERVIEW REGIONAL MEDICAL CENTER
Enterprise Value: $-70.2M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-70.2M
Enterprise Value
$-24.3M
PV of Cash Flows
$-46.0M
PV of Terminal Value
$-74.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $104.5M | $-3.3M | -3.0% | $-7.7M | $-7.0M |
| Year 2 | $107.7M | $-2.3M | -2.0% | $-6.8M | $-5.7M |
| Year 3 | $110.9M | $-1.2M | -1.0% | $-5.9M | $-4.5M |
| Year 4 | $114.2M | $-0.7M | -1.0% | $-5.5M | $-3.8M |
| Year 5 | $117.6M | $-0.4M | -0.0% | $-5.4M | $-3.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-70.2M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$101.5M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.03623512813702607
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5